News

Health Canada Extends The Approval Of Evkeeza® (Evinacumab) To Children As Young As 6-Months Old With Homozygous Familial Hypercholesterolemia (Hofh)
First and only medicine approved by Health Canada for patients as young as 6-months of age with HoFH, an ultrarare, inherited form of high cholestero ...